Methodical principles of assessment of financial compensation for clinical trial volunteer participants
DOI:
https://doi.org/10.14739/2310-1210.2013.5.19110Keywords:
organization of clinical trials, encouraging of the volunteers participation, financial compensation, possible discomfortAbstract
Introduction. Due to the necessity to obtain the reliable results of a clinical trial and to distribute it to the general population of patients the problem of recruiting the adequate number of individuals to participate in the study as objects of observation in the group receiving the investigational medicinal product or as a member of the control group should to be solved.
Aim of study. The aim of our study was to research and to justify practically the methodological approaches to determining financial compensation for participation of volunteers in the clinical trials and the appropriate methods of its calculation.
Material and methods. For the purpose of determining the baseline factors for calculating the hourly compensation the survey of healthy volunteers and of expert professionals as well as the analysis of its results have been done.
Questioning healthy volunteers regarding their attitudes towards inconvenience and discomfort during participation in clinical trials was held at the Ukrainian clinical research centers. Survey participants number was 99, they were healthy volunteers who took part in the first phase clinical trial or bioequivalence studies.
The expert survey included questioning of the 193 professionals from Ukrainian clinical research centers, CRO, pharmaceutical manufacturers – research sponsors and collaborators State Expert Center Ministry of Health of Ukraine, who were involved in the planning, organization, implementation and evaluation of clinical trials as well as their regulatory control.
Results of study. Using the method of pairwise comparisons and iterative refinement procedures the collective estimate of experts questionnaire results has been performed, by the results of which the nine indicators have been identified and the importance of each of them as units of discomfort have been established.
Motivational factors of voluntary participation in clinical trials have been studied. Motivation system for participation in clinical trials by patients and healthy volunteers has been rationalized, whereas methods of calculating monetary compensation for such participation have been suggested. The two methods of calculating of the financial compensation were proposed: first - hourly compensation for the time which was spent on clinical trials, the second - hourly-bonus compensation for the possible discomfort and inconvenience of participation in clinical trials in accordance with the ethical rules for research involving people as objects of observation.
Conclusion. Achievement of the organizational and financial constituent ensuring participation of volunteers in a clinical trial on the one hand should assure the appropriate experimental foundation for reliable research conducting and on other hand should focus attention on the fulfillment of mental and ethical rules for investigations involving human as a studied object. Basing on the results of an analysis and the survey performed which involved qualified experts regarding aspects affecting volunteers enrollment in a clinical trial, the scientifically substantiated system of the volunteers discomfort and inconvenience assessment in a clinical trial has been proposed, which includes criteria: study duration, adverse events/adverse reactions possibility, blood sampling during study, discomfort caused by study design, inconvenience to participate in a clinical trial. Two techniques for calculation of the financial compensation for healthy volunteers participation in a clinical trial have been proposed: the first one is the payment by the hour spent for participation in a study, and the second one is the hourly pay with bonus for possible discomfort caused by involvement in a clinical trial. In the further study authors plan to research the aspects of risk assessment associated with volunteers participation in a clinical trial and its considering as an additional constituent in the process of the calculation of financial incentives to participate in a clinical trial.
References
Аналіз факторів дискомфорту з урахуванням вимог до належного планування клінічних випробувань за участю здорових добровольців / В.Є. Доброва, М.Г. Старченко, І.А. Зупанець, О.М. Котенко // Запорожский мед. журн. – 2011. – Т. 13, №5. – С. 16–21.
Давнис В.В. Прогнозные модели экспертных предпочтений: Монография / В.В. Давнис, В.И. Тинякова. – Воронеж: Изд-во Воронеж. гос. ун-та, 2005. – 248 с.
Державна служба статистики України. Державні статистичні звіти [Електронний ресурс]. – Режим доступу: www.ukrstat.gov.ua.
Доброва В.Є. Аналіз думки добровольців – учасників клінічних випробувань відносно факторів дискомфорту / В.Є. Доброва, М.Г. Старченко, Т.Ю. Колодєзна // Зб. наукових праць співробітників НМАПО ім. П.Л. Шупика. – 2012. – Вип. 21, кн. 3. – С. 695–699.
Клинические испытания лекарств / под ред. В.И. Мальцева, Т.К. Ефимцевой, Ю.Б. Белоусова, В.Н. Коваленко и др. – К.: МОРИОН, 2006. – 456 с.
Корнацький В.М. Правові проблеми клінічних випробувань лікарських засобів в Україні / В.М. Корнацький, Т.В. Талаєва, О.В. Сілантьєва // Вісник Академії адвокатури України. – 2012. – Вип. 2 (24). – С. 39–45.
Лікарські засоби. Належна клінічна практика : настанова СТ-Н МОЗУ 42-7.0:2008. – К. : «Моріон», 2009. – 67 с.
Обґрунтування та розробка методики розрахунку компенсації участі здорових добровольців у клінічних випробуваннях з урахуванням сучасних вимог / В.Є. Доброва, І.А. Зупанець, М.Г. Старченко, О.М. Котенко // Управління, економіка та забезпечення якості в фармації. – 2011. – Вип. 5 (19). – С. 9–14.
Орлов А.И. Теория принятия решений: учеб. / А.И. Орлов. – М.: Изд-во «Экзамен», 2007. – 576 с.
Сілантьєва О.В. Етичні аспекти набору та утримання пацієнтів у клінічних дослідженнях / О.В. Сілантьєва // Клинические исследования лекарственных средств в Украине: мат. работы третьей науч.-практ. конф. с междунар. участием, Киев, 4–5 нояб. 2010 г. – К.: МОРИОН, 2010. – С. 61.
Beckford L. Ethics and the payment of research subjects / L. Beckford, M.R. Broome // Psychiatry. – 2007. – Vol. 6, №2. – Р. 83–85.
Bhatt A. Quality of clinical trials: A moving target / A. Bhatt // Perspectives Clinical Research. – 2011. – Vol. 2. – P. 124–128.
Downie J. The power of money: commercialization of research conducted in public institutions / J. Downie // Otago Law Rev. – 2006. – Vol. 11, №2. – P. 305–325.
Guidelines for Remuniration of Research Subjects in the Intramural Research Program and Registration in the Clinical Research Volunteer Program Database [Електронний ресурс] / National Institute of Health. OHSR Information Sheets/Forms. Revised: 02/09, Edited 02/09. – Режим доступу: http://ohsr.od.nih.gov/info/info.html.
Iltis A. S. Payments to Normal Healthy Volunteers in Phase 1 Trials:Avoiding Undue Infl uence While Distributing Fairly the Burdens of Research Participation / A. S. Iltis // Journal of Medicine and Philosophy. – 2009. – Vol. 46, №3. – P. 21–23.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
